Log in

Relevant bibliographies by topics / FNH / Journal articles

To see the other types of publications on this topic, follow the link: FNH.

Journal articles on the topic 'FNH'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'FNH.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Katrich, Alexey N., Nikolai S. Ryabinin, Sergey V. Polshikov, and Nikita A. Katrich. "CONTRAST-ENCHANCED ULTRASOUND IN THE DIFFERENTIAL DIAGNOSIS OF FOCAL NODULAR HYPERPLASIA AND HEPATIC ADENOMA." Kuban Scientific Medical Bulletin 26, no. 2 (2019): 50–63. http://dx.doi.org/10.25207/1608-6228-2019-26-2-50-63.

Full text

Abstract:

Aim. To increase the effectiveness of the differential diagnosis of benign focal lesions of the liver using contrast-enhanced ultrasound (CEUS).Materials and methods. A retrospective analysis of the examination results of 37 patients with morphologically confi rmed liver benign tumors was carried out. According to the morphological data, the patients were divided into two groups: 22 patients with focal nodular hyperplasia (FNH) and 15 patients with hepatocellular adenoma (HCA). All the patients underwent multiparametric ultrasound examination using CEUS.Results. According to the obtained data,

APA, Harvard, Vancouver, ISO, and other styles

2

Demarco, Mario P., Perry Shen, Robert F. Bradley, and Edward A. Levine. "Intraperitoneal Hemorrhage in a Patient with Hepatic Focal Nodular Hyperplasia." American Surgeon 72, no. 6 (2006): 555–59. http://dx.doi.org/10.1177/000313480607200620.

Full text

Abstract:

Focal nodular hyperplasia (FNH) is a common benign liver tumor that is often confused with hepatic adenoma. Despite the benign course of both lesions, hepatic adenomas are associated with rupture and bleeding, and suggested management often includes prophylactic surgical resection. FNH lesions are thought to not rupture or bleed, and traditional management does not include resection. We report the case of a woman with FNH who presented with intraperitoneal hemorrhage after the rupture of a FNH lesion. Only six previous documented cases of hemoperitoneum associated with FNH have ever been repor

APA, Harvard, Vancouver, ISO, and other styles

3

Langrehr, J. M., R. Pfitzmann, M. Hermann, et al. "Hepatocellular carcinoma in association with hepatic focal nodular hyperplasia." Acta Radiologica 47, no. 4 (2006): 340–44. http://dx.doi.org/10.1080/02841850600570474.

Full text

Abstract:

Purpose: To report the association between hepatocellular carcinoma (HCC) and hepatic focal nodular hyperplasia (FNH) and the possible impact on clinical decision-making with regard to resective approaches in patients with FNH. Material and Methods: We retrospectively analyzed the findings in 77 adult patients who underwent liver resections for FNH between October 1989 and September 2001 at our center. HCC within the confines of FNH was found in two patients. We demonstrate the magnetic resonance imaging (MRI) and macroscopic and microscopic findings. Results: Presurgical MRI demonstrated hete

APA, Harvard, Vancouver, ISO, and other styles

4

Hamada, Koichi, Satoshi Saitoh, Noriyuki Nishino, et al. "An elderly man with progressive focal nodular hyperplasia." Clinical Journal of Gastroenterology 13, no. 3 (2019): 413–20. http://dx.doi.org/10.1007/s12328-019-01072-9.

Full text

Abstract:

AbstractPatients with focal nodular hyperplasia (FNH) develop benign hepatocellular nodules. FNH most frequently occurs in young women. There are no reports of the onset of FNH in elderly men. We report a case of FNH in an elderly man, whose nodules increased in number and size. The patient underwent surgery for carcinoma of the left renal pelvis at 69 years of age; no liver masses were noted on yearly follow-up contrast-enhanced computed tomography (CECT). Ten years later, CECT revealed a hepatic mass, and magnetic resonance imaging suggested FNH. The nodules increased in number and size in s

APA, Harvard, Vancouver, ISO, and other styles

5

Muguti, G., N. Tait, A. Richardson, and J. M. Little. "Hepatic Focal Nodular Hyperplasia: A Benign Incidentaloma or a Marker of Serious Hepatic Disease?" HPB Surgery 5, no. 3 (1992): 171–80. http://dx.doi.org/10.1155/1992/25139.

Full text

Abstract:

Amongst 17 patients with hepatic focal nodular hyperplasia (FNH) encountered at Westmead Hospital between 1981 and 1990, FNH was found in association with hepatocellular carcinoma (HCC) in three (3/ 17), one male and two females, one of whom also had peliosis and an hepatic adenoma. FNH was also found in association with other conditions which may affect hepatic function, structure or circulation, including chronic obstructive airways disease (2), congestive cardiomyopathy (1), chronic active hepatitis (1), granulomatous hepatitis (1), coeliac artery stenosis (1) and metastatic malignant melan

APA, Harvard, Vancouver, ISO, and other styles

6

Xue, Dan-Qing, and Lan Yang. "Development of Focal Nodular Hyperplasia after Cyclophosphamide-Based Chemotherapy in a Patient with Breast Cancer." Case Reports in Hepatology 2018 (October 22, 2018): 1–4. http://dx.doi.org/10.1155/2018/5409316.

Full text

Abstract:

Focal nodular hyperplasia (FNH) is the second most common liver cell-derived benign tumor. It is postulated that chemotherapy-induced hepatic circulatory abnormalities, like sinusoidal obstruction syndrome (SOS), could lead to the development of FNH. Cyclophosphamide was also reported to induce SOS in a synergistic effect with total body irradiation. However, none of cyclophosphamide-related FNH had ever been reported before. In this case report, we present a female patient who was treated with neoadjuvant chemotherapy of cyclophosphamide (500mg/m2)-docetaxel (75mg/m2)-pharmorubicin (90mg/m2)

APA, Harvard, Vancouver, ISO, and other styles

7

Wasif, Nabil, Sebastian Sasu, William C. Conway, and Anton Bilchik. "Focal Nodular Hyperplasia: Report of an Unusual Case and Review of the Literature." American Surgeon 74, no. 11 (2008): 1100–1103. http://dx.doi.org/10.1177/000313480807401112.

Full text

Abstract:

Focal nodular hyperplasia (FNH) is the second most common benign lesion of the liver and a common differential in the workup of solid liver lesions. With increasing use of modern imaging modalities FNH is becoming clinically more relevant. We present a case of pedunculated FNH presenting as a pericholecystic mass. This was resected laparoscopically due to persistent symptoms and uncertainty in diagnosis. We summarize the current literature with regard to the diagnosis, etiology, and management of FNH lesions.

APA, Harvard, Vancouver, ISO, and other styles

8

Gainey, Christina S., Suzanne L. Palmer, Edward Mena, Navpreet Kaur, Yuna Gong, and Jeffrey A. Kahn. "Diagnosis of Focal Nodular Hyperplasia (FNH) after Liver Transplantation." Case Reports in Transplantation 2020 (October 2, 2020): 1–6. http://dx.doi.org/10.1155/2020/8824099.

Full text

Abstract:

Following liver transplantation (LT), recipients can develop benign and malignant hepatic masses just like any other patient. Patients transplanted for hepatocellular carcinoma (HCC) undergo surveillance imaging, and any new mass seen on imaging must be carefully evaluated to rule out recurrent cancer. Focal nodular hyperplasia (FNH) is a benign tumor of the liver that most often occurs in women and is rarely symptomatic. It is important to distinguish FNH from more serious etiologies, such as recurrent HCC and other malignancies, since the treatments differ greatly. To date, there have been v

APA, Harvard, Vancouver, ISO, and other styles

9

Takeda, Nobutaka, Atsunori Tsuchiya, Kazuki Natsui, et al. "Novel Strategy for Diagnosis of Focal Nodular Hyperplasia Using Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid: Enhanced Magnetic Resonance Imaging and Magnetic Resonance Elastography." Case Reports in Gastroenterology 15, no. 2 (2021): 507–12. http://dx.doi.org/10.1159/000516552.

Full text

Abstract:

Focal nodular hyperplasia (FNH) is the second most frequent benign liver tumor, and it is a fiber-rich stiff lesion. Typically, FNH can be diagnosed by imaging without biopsy. However, liver biopsy and diagnostic resection may be required to differentiate atypical FNH from other liver tumors, such as hepatocellular adenoma (HCA). Therefore, improved noninvasive diagnostic methods are needed. We experienced 2 cases where combination of magnetic resonance elastography (MRE) and gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) help

APA, Harvard, Vancouver, ISO, and other styles

10

Katrich, A. N., and S. V. Polshikov. "The role of ultrasound in the differential diagnosis of liver tumors." Innovative medicine of Kuban, no. 4 (November 22, 2020): 35–42. http://dx.doi.org/10.35401/2500-0268-2020-20-4-35-42.

Full text

Abstract:

Background. Liver lesions are increasingly found in a huge number of patients. Ultrasound (US) is the method of choice in liver lesion characterization. The limitations of traditional US techniques are well known. Multiparametric ultrasound (MPUS) includes multiple facets of the US examination, and their combination can significantly improve the diagnostic capabilities of the method.Objective. To evaluate the capabilities of MPUS in the differential diagnosis of liver tumors.Material and Methods. A retrospective analysis included 172 patients with morphologically confirmed liver tumors. All pa

APA, Harvard, Vancouver, ISO, and other styles

11

Sagoyan, G. B., T. V. Shamanskaya, D. Yu Kachanov, et al. "Focal nodular liver hyperplasia as a late complication that occurs after autologous hematopoietic stem cell transplantation in children with neuroblastoma (clinical case and literature review)." Russian Journal of Pediatric Hematology and Oncology 6, no. 3 (2019): 94–102. http://dx.doi.org/10.21682/2311-1267-2019-6-3-94-102.

Full text

Abstract:

Focal nodular hyperplasia (FNH) is a regenerative volumetric liver formation that can occur as a result of the reaction of hepatocytes to local vascular circulatory disorders and is one of the late complications in patients who received high-dose chemotherapy followed by hematopoietic stem cell transplantation. This article presents a description of two clinical cases of development of liver FNH in patients with high-risk neuroblastoma identified in the late stages from the end of specific treatment. A possible reason for the development of liver FNH in these patients could be the use of alkyl

APA, Harvard, Vancouver, ISO, and other styles

12

Campos Amico, Enio, Izadora K. de Souza, Juliana R. Grigório Trigueiro, Fernanda Cunha Miranda, Rogério Lacerda Sousa, and Adriano de Araújo Lima Liguori. "Should Focal Nodular Hyperplasia Still be Operated Upon? Analysis of a Case Series." Digestive Diseases 37, no. 4 (2019): 309–14. http://dx.doi.org/10.1159/000496430.

Full text

Abstract:

Background: Focal nodular hyperplasia (FNH) is a frequent benign liver lesion. Its course is considered benign, and there is no recommendation for its treatment. Nevertheless, the literature presents a high incidence of surgery. Aim: To evaluate the results of conservative treatment in a series of patients with presumed FNH. Methods: The study included patients diagnosed with FNH from May 2007 to July 2017 based on conventional imaging or magnetic resonance imaging with liver-specific contrast (MRI-LSC) or lesion biopsy (histology/immunohistochemical analysis). Patients were followed clinicall

APA, Harvard, Vancouver, ISO, and other styles

13

Chandan, Vishal S., Sejal S. Shah, Taofic Mounajjed, Michael S. Torbenson, and Tsung-Teh Wu. "Copper deposition in focal nodular hyperplasia and inflammatory hepatocellular adenoma." Journal of Clinical Pathology 71, no. 6 (2017): 504–7. http://dx.doi.org/10.1136/jclinpath-2017-204820.

Full text

Abstract:

AimsTo examine copper deposition in focal nodular hyperplasia (FNH) and inflammatory hepatocellular adenoma (IHA) and to determine if it can play a role in their differentiation.Methods28 FNHs and 19 IHAs from surgical resections showing typical morphological and immunohistochemical features were stained with rhodanine to evaluate for copper deposition. Histological features such as nodularity, fibrous bands, ductular proliferation, steatosis, ballooned hepatocytes and lymphocytic inflammation were also scored.ResultsCopper deposition was detected in 96% (27/28) of FNHs and 37% (7/19) of IHAs,

APA, Harvard, Vancouver, ISO, and other styles

14

Frimand Rönnow, Carl-Fredrik, Bengt Jeppsson, and Henrik Thorlacius. "A New Needle Holder Facilitating Palm Grip Suturing." European Surgical Research 54, no. 1-2 (2014): 55–63. http://dx.doi.org/10.1159/000367941.

Full text

Abstract:

Purpose: The finger grip and the palm grip are the most common needle holder grips for hand suturing in surgery. The major advantages of the palm grip are an increased versatility and the possibility to apply controlled force. However, there is a risk for a potential loss of precision and uncontrolled movement of the needle when disengaging the ratchet mechanism of the palmed instrument. The purpose of this study was to develop a new needle holder, referred to as the Frimand needle holder (FNH), and evaluate surgeons' perception of it. It was designed to overcome the above-mentioned disadvanta

APA, Harvard, Vancouver, ISO, and other styles

15

Chrischilles, Elizabeth, David J. Delgado, Bradley S. Stolshek, Grant Lawless, Moshe Fridman, and William B. Carter. "Impact of Age and Colony-Stimulating Factor Use on Hospital Length of Stay for Febrile Neutropenia in CHOP-Treated Non-Hodgkin's Lymphoma." Cancer Control 9, no. 3 (2002): 203–11. http://dx.doi.org/10.1177/107327480200900303.

Full text

Abstract:

Background In intermediate-grade non-Hodgkin's lymphoma (NHL) patients, full-dose CHOP improves survival but increases myelosuppression, causing febrile neutropenia hospitalization (FNH) in 28% of patients 65 years of age or greater. Several risk factors for FNH are known, but their relationship to length of stay (LOS), an indicator of the total burden of FNH, is unclear. Methods We conducted a study to identify factors associated with the incidence, recurrence, and duration of hospitalizations for FN and to describe the frequency of administration of colony-stimulating factor (CSF) as primary

APA, Harvard, Vancouver, ISO, and other styles

16

Jia, Yingmei, Huasong Cai, Meng Wang, et al. "Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules." Contrast Media & Molecular Imaging 2019 (July 17, 2019): 1–10. http://dx.doi.org/10.1155/2019/2030147.

Full text

Abstract:

Objectives. To assess the efficacy of diffusion kurtosis imaging (DKI) and compare DKI-derived parameters with conventional diffusion-weighted imaging (DWI) for distinguishing hepatocellular carcinoma (HCC) from benign hepatic nodules including focal nodular hyperplasia (FNH), hemangioma, and hepatocellular adenoma (HCA). Materials and Methods. 151 patients with 182 hepatic nodules (114 HCCs and 68 benign nodules including 33 FNHs, 29 hemangiomas, and 6 HCAs) were analyzed. Preoperative MRI examinations including DKI (b values: 0, 200, 500, 800, 1500, and 2000 sec/mm2) were performed, and kurt

APA, Harvard, Vancouver, ISO, and other styles

17

de Wert, L. A., S. A. Huisman, F. Imani, et al. "Appearance of Focal Nodular Hyperplasia after Chemotherapy in Two Patients during Follow-Up of Colon Carcinoma." Case Reports in Surgery 2021 (April 3, 2021): 1–4. http://dx.doi.org/10.1155/2021/6676109.

Full text

Abstract:

Surgical liver resection is a treatment option in patients with resectable colorectal liver metastases. We present two cases of focal nodular hyperplasia (FNH) development after treatment with oxaliplatin during follow-up of colon carcinoma. The first case was a 40-year-old male patient who developed multiple liver lesions suspect for metastatic disease four years after he had undergone laparoscopic right-sided hemicolectomy and adjuvant chemotherapy (capecitabine and oxaliplatin). He underwent a metastasectomy of segments three and four and microwave ablation (MWA) of the lesion in segment on

APA, Harvard, Vancouver, ISO, and other styles

18

Yoneda, Norihide, Osamu Matsui, Azusa Kitao, et al. "Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images." Japanese Journal of Radiology 30, no. 6 (2012): 499–508. http://dx.doi.org/10.1007/s11604-012-0085-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Sansone, Vito, Lorenzo Falsetti, Francesco Tovoli, Rita Golfieri, Matteo Cescon, and Fabio Piscaglia. "An Uncommon Focal Liver Lesion: Intrahepatic Splenosis." Journal of Gastrointestinal and Liver Diseases 29, no. 2 (2020): 257–62. http://dx.doi.org/10.15403/jgld-617.

Full text

Abstract:

Multiple focal liver lesions were incidentally detected in a patient screened by ultrasound for a recent diagnosis of lower limb deep vein thrombosis, for which anticoagulation had been initiated. Past medical history reported a post-traumatic splenectomy 15 years before. Magnetic resonance imaging (MRI) and contrast-enhanced ultrasound (CEUS) showed a subcapsular lesion in liver segment 5 consistent with focal nodular hyperplasia (FNH) and multiple other nodules, with a different pattern from the former, judged as probable hepatic adenomas by MRI but probable hemangiomas by CEUS (hyperenhance

APA, Harvard, Vancouver, ISO, and other styles

20

Crawford, Daniel, Sailen Naidu, Indravadan Patel, Grace Knuttinen, Sadeer Alzubaidi, and Rahmi Oklu. "Bland Embolization of Benign Liver Tumors: Review of the Literature and a Single Center Experience." Journal of Clinical Medicine 10, no. 4 (2021): 658. http://dx.doi.org/10.3390/jcm10040658.

Full text

Abstract:

Transarterial embolization has shown promise as a safe, effective, and less invasive treatment modality for benign liver lesions (hemangioma, focal nodular hyperplasia (FNH), and hepatic adenoma (HA)) with fewer complications compared to surgical intervention. There is no consensus regarding the most appropriate embolization material(s) for the treatment of benign liver tumors. The purpose of this study was to review the current literature regarding the transarterial embolization of benign liver tumors and to share our single center experience. This was a non-blinded, retrospective, single-ins

APA, Harvard, Vancouver, ISO, and other styles

21

Balabaud, Charles, Wesal R. Al-Rabih, Pei-Jer Chen, et al. "Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification." International Journal of Hepatology 2013 (2013): 1–12. http://dx.doi.org/10.1155/2013/268625.

Full text

Abstract:

Focal nodular hyperplasia (FNH) and hepatocellular adenoma (HCA) are benign hepatocellular tumors. The risk of bleeding and malignant transformation of HCA are strong arguments to differentiate HCA from FNH. Despite great progress that has been made in the differential radiological diagnosis of the 2 types of nodules, liver biopsy is sometimes necessary to separate the 2 entities. Identification of HCA subtypes using immunohistochemical techniques, namely,HNF1A-inactivated HCA (35–40%), inflammatory HCA (IHCA), and beta-catenin-mutated inflammatory HCA (b-IHCA) (50–55%), beta-catenin-activated

APA, Harvard, Vancouver, ISO, and other styles

22

Wagner, R. C., M. Koenigsberg, and J. P. Wexler. "US case of the day. Focal nodular hyperplasia (FNH)." RadioGraphics 16, no. 4 (1996): 974–78. http://dx.doi.org/10.1148/radiographics.16.4.8835988.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Sumiyoshi, Maho, Masahiro Sakanaka, and Yoshiyuki Kimura. "Chronic intake of a high-cholesterol diet resulted in hepatic steatosis, focal nodular hyperplasia and fibrosis in non-obese mice." British Journal of Nutrition 103, no. 3 (2009): 378–85. http://dx.doi.org/10.1017/s0007114509991772.

Full text

Abstract:

We investigated the effects of a high-cholesterol (HC) diet administered long term (25 or 55 weeks) on metabolic disorders including hepatic damage in mice. The mice were fed the HC diet (15 % milk fat, 1·5 % cholesterol and 0·1 % cholic acid, w/w) for 25 or 55 weeks. Body and adipose tissue weights were similar to those of mice fed a control diet. Consumption of the HC diet long term resulted in hypercholesterolaemia, hepatic steatosis and gallstones. In addition, focal nodular hyperplasia (FNH) and mild fibrosis of the liver developed in all mice fed the HC diet for 55 weeks. Plasma levels o

APA, Harvard, Vancouver, ISO, and other styles

24

Bioulac-Sage, Paulette, and Charles Balabaud. "Early stage in the development of focal nodular hyperplasia (FNH)." Journal of Hepatology 36 (April 2002): 186. http://dx.doi.org/10.1016/s0168-8278(02)80655-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Tohara, Keiji, Seigo Sakaguchi, Kazuchika Mihara, et al. "IMO 1206 Hepatic focal nodular hyperplasia (FNH)-ultrasonic doppler diagnosis." Ultrasound in Medicine & Biology 23 (January 1997): S21. http://dx.doi.org/10.1016/s0301-5629(97)80405-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Schmitz, D., H. H. Köhler, C. P. Heußel, H. F. Löhr, and P. R. Galle. "Eine lymphomähnliche Präsentation einer fokalen nodulären Hyperplasie (FNH) der Leber." Zeitschrift für Gastroenterologie 39, no. 3 (2001): 219–24. http://dx.doi.org/10.1055/s-2001-11765.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Kojiro, Masamichi, Sadayuki Okudaira, and Osamu Nakashima. "Clinicopathologic characteristics of focal nodular hyperplasia (FNH) of the liver." Journal of Hepato-Biliary-Pancreatic Surgery 3, no. 2 (1996): 106–10. http://dx.doi.org/10.1007/bf02350919.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Franchi-Abella, Stéphanie, and Sophie Branchereau. "Benign Hepatocellular Tumors in Children: Focal Nodular Hyperplasia and Hepatocellular Adenoma." International Journal of Hepatology 2013 (2013): 1–11. http://dx.doi.org/10.1155/2013/215064.

Full text

Abstract:

Benign liver tumors are very rare in children. Most focal nodular hyperplasia (FNH) remain sporadic, but predisposing factors exist, as follows: long-term cancer survivor (with an increasing incidence), portal deprivation in congenital or surgical portosystemic shunt. The aspect is atypical on imaging in two-thirds of cases. Biopsy of the tumor and the nontumoral liver is then required. Surgical resection will be discussed in the case of large tumors with or without symptoms. In the case of associated vascular disorder with portal deprivation, restoration of the portal flow will be discussed i

APA, Harvard, Vancouver, ISO, and other styles

29

Newerla, Caroline, Fabienne Schaeffer, Luigi Terracciano, and Joachim Hohmann. "Multiple FNH-Like Lesions in a Patient with Chronic Budd-Chiari Syndrome: Gd-EOB-Enhanced MRI and BR1 CEUS Findings." Case Reports in Radiology 2012 (2012): 1–5. http://dx.doi.org/10.1155/2012/685486.

Full text

Abstract:

A-26-year old female patient with chronic Budd-Chiari syndrome due to different underlying blood disorders applied for a two-year followup of the liver with Gadolinium-ethoxybenzyl-diethylenetriaminepentaacetic-acid-(Gd-EOB-DTPA-) enhanced MRI. The liver function tests were raised. Besides showing a progressive hepatosplenomegaly and a cirrhotic liver alteration, the MRI revealed multiple new nodular lesions in all liver segments. These lesions showed typical patterns in the precontrast images, while there was an arterial and a persistent portal venous enhancement. In the hepatobiliary liver-s

APA, Harvard, Vancouver, ISO, and other styles

30

Seitz, K., C. Greis, A. Schuler, et al. "Frequency of Tumor Entities among Liver Tumors of Unclear Etiology Initially Detected by Sonography in the Noncirrhotic or Cirrhotic Livers of 1349 Patients." Ultraschall in der Medizin - European Journal of Ultrasound 32, no. 06 (2011): 598–603. http://dx.doi.org/10.1055/s-0031-1281858.

Full text

Abstract:

Zusammenfassung Ziel: Untersuchung der Häufigkeit von verschiedenen soliden fokalen Leberläsionen (SFLL) in nicht zirrhotischen und zirrhotischen Lebern unter besonderer Berücksichtigung der Häufigkeit der Metastasierung in Zirrhoselebern. Material und Methoden: Das Patientenkollektiv der DEGUM-Multicenterstudie (n = 1349) wurde reevaluiert und in ein Subkollektiv A ohne (n = 1067) und B mit Zirrhose (n = 282) unterteilt. Die verschiedenen Tumorentitäten waren zu 74,6 % histologisch gesichert (n = 1006). Ergebnisse: Im Subkollektiv A fanden sich 385 Fälle mit Metastasen (36,4 %) und 65 mit HCC

APA, Harvard, Vancouver, ISO, and other styles

31

SAEKI, Hideki, Motonobu SUGIMOTO, Katsunori AIKAWA, et al. "A case of focal nodular hyperplasia(FNH) accompanied by fatty liver." Kanzo 29, no. 1 (1988): 104–10. http://dx.doi.org/10.2957/kanzo.29.104.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Wruck, U. "Characteristic of Focal Nodular Hyperplasia (FNH) in 3D Colour Doppler Ultrasound." European Journal of Ultrasound 6 (November 1997): S34. http://dx.doi.org/10.1016/s0929-8266(97)87264-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

De Fazio, Cristina, Pierangelo Fasani, Maria F. Donato, et al. "The course of focal nodular hyperplasia (FNH) in 24 asymptomatic carriers." Gastroenterology 118, no. 4 (2000): A1434. http://dx.doi.org/10.1016/s0016-5085(00)81631-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Bonacchi, Giovanni, Marco Becciolini, and Marta Seghieri. "Superb microvascular imaging: a potential tool in the detection of FNH." Journal of Ultrasound 20, no. 2 (2017): 179–80. http://dx.doi.org/10.1007/s40477-017-0240-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Sriyanti, Ida, Meily P. Agustini, Jaidan Jauhari, Sukemi Sukemi, and Zainuddin Nawawi. "Electrospun Nylon-6 Nanofibers and Their Characteristics." Jurnal Ilmiah Pendidikan Fisika Al-Biruni 9, no. 1 (2020): 9–19. http://dx.doi.org/10.24042/jipfalbiruni.v9i1.5747.

Full text

Abstract:

The purposes of this research were to investigate the synthesized Nylon-6 nanofibers using electrospinning technique and their characteristics. The method used in this study was an experimental method with a quantitative approach. Nylon-6 nanofibers have been produced using the electrospinning method. This fiber was made with different concentrations, i.e. 20% w/w (FN1), 25% w/w (FN2), and 30% w/w (FN3). The SEM results show that the morphology of all nylon-6 nanofibers) forms perfect fibers without bead fiber. Increasing fiber concentration from 20% w/w to 30% w/w results in bigger morphology

APA, Harvard, Vancouver, ISO, and other styles

36

Kotzerke, J., R. Schwarzrock, P. Heintz, R. Ringe, and H. Hundeshagen. "Gleichzeitiges Auftreten einer fokal nodulären Hyperplasie (FNH) und eines Hämangioms der Leber." RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 151, no. 12 (1989): 742–44. http://dx.doi.org/10.1055/s-2008-1047281.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Lazar, A., H. Menzel, I. Cascorbi, et al. "CYP1A1 alleles in women with focal nodular hyperplasia of the liver (FNH)." Int. Journal of Clinical Pharmacology and Therapeutics 42, no. 02 (2004): 78–82. http://dx.doi.org/10.5414/cpp42078.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Zhao, Jingfeng, Jixia Ren, Nan Wang та ін. "Crystal structure of the second fibronectin type III (FN3) domain from human collagen α1 type XX". Acta Crystallographica Section F Structural Biology Communications 73, № 12 (2017): 695–700. http://dx.doi.org/10.1107/s2053230x1701648x.

Full text

Abstract:

Collagen α1 type XX, which contains fibronectin type III (FN3) repeats involving six FN3 domains (referred to as the FN#1–FN#6 domains), is an unusual member of the fibril-associated collagens with interrupted triple helices (FACIT) subfamily of collagens. The results of standard protein BLAST suggest that the FN3 repeats might contribute to collagen α1 type XX acting as a cytokine receptor. To date, solution NMR structures of the FN#3, FN#4 and FN#6 domains have been determined. To obtain further structural evidence to understand the relationship between the structure and function of the FN3

APA, Harvard, Vancouver, ISO, and other styles

39

Gaiani, S., F. Piscaglia, L. Masi, et al. "Pattern of enhancement timing in focal nodular hyperplasia (FNH) investigated by perfusional angiosonography." Ultrasound in Medicine & Biology 29, no. 5 (2003): S155. http://dx.doi.org/10.1016/s0301-5629(03)00626-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Kurtaran, Amir, Alexander Becherer, Franz Pfeffel, et al. "18F-Fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver." Liver International 20, no. 6 (2000): 487–90. http://dx.doi.org/10.1034/j.1600-0676.2000.020006487.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Aznar, D. L??pez, Reyes Ojeda, E. Uruburu Garcia, et al. "Focal Nodular Hyperplasia (FNH): A Potential Cause of False-Positive Positron Emission Tomography." Clinical Nuclear Medicine 30, no. 9 (2005): 636–37. http://dx.doi.org/10.1097/01.rlu.0000174209.49753.a5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Moga, Tudor Voicu, Alina Popescu, Ioan Sporea, et al. "Is Contrast Enhanced Ultrasonography a useful tool in a beginner’s hand? How much can a Computer Assisted Diagnosis prototype help in characterizing the malignancy of focal liver lesions?" Medical Ultrasonography 19, no. 3 (2017): 252. http://dx.doi.org/10.11152/mu-936.

Full text

Abstract:

Aim: Contrast enhanced ultrasound (CEUS) improved the characterization of focal liver lesions (FLLs), but is an operatordependent method. The goal of this paper was to test a computer assisted diagnosis (CAD) prototype and to see its benefit in assisting a beginner in the evaluation of FLLs.Material and method: Our cohort included 97 good quality CEUS videos[34% hepatocellular carcinomas (HCC), 12.3% hypervascular metastases (HiperM), 11.3% hypovascular metastases (HipoM), 24.7% hemangiomas (HMG), 17.5% focal nodular hyperplasia (FNH)] that were used to develop a CAD prototype based on an algo

APA, Harvard, Vancouver, ISO, and other styles

43

Shah, S., P. Kansakar, and P. Vaidya. "Early experience in pediatric hepatic resection at IOM, TUTH." Journal of Society of Surgeons of Nepal 18, no. 3 (2016): 50. http://dx.doi.org/10.3126/jssn.v18i3.15312.

Full text

Abstract:

Total 5 pediatric hepatectomy were performed at IOM TUTH during last 2 years. Three children were cases of hepatoblastoma and two were cases of symptomatic focal noduler hyperplasia (FNH). Two left hepatectomy for left hepatoblastoma, one right hepatectomy for right hepatoblastoma were performed and 2 non-anatomical resection of mass with 2 cm margin for focal nodular hyperplasia were performed. Median hospital stay was 7 days. Post operative period at hospital was uneventful. Three cases of hepatoblastoma received neoadjuvant and adjuvant chemotherapy. Among 3 cases of hepatoblastoma, there w

APA, Harvard, Vancouver, ISO, and other styles

44

Geara, A., A. Plessier, Y. Consigny, B. Condat, D. Valla, and V. Vilgrain. "Evolution des nodules « FNH-like » du syndrome de Budd-Chiari : quels facteurs sont responsables." Journal de Radiologie 87, no. 10 (2006): 1354. http://dx.doi.org/10.1016/s0221-0363(06)87235-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Grieser, Christian, Ingo G. Steffen, Incken-Birthe Kramme, et al. "Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience." European Radiology 24, no. 6 (2014): 1339–48. http://dx.doi.org/10.1007/s00330-014-3144-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

KURUMIYA, Takashi, Takashi TOMIDA, Yasuo KATSUMINE, and Masaya KUZE. "A CASE OF FNH PRESENTED DIFFICULTY IN PREOPERATIVE DIAGNOSIS DUE TO ITS SPECIFIC MORPHOLOGY." Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 60, no. 4 (1999): 1050–58. http://dx.doi.org/10.3919/jjsa.60.4_1050.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Haring, Martijn P. D., Frans J. C. Cuperus, Evelien W. Duiker, Robbert J. de Haas, and Vincent E. de Meijer. "Scoping review of clinical practice guidelines on the management of benign liver tumours." BMJ Open Gastroenterology 8, no. 1 (2021): e000592. http://dx.doi.org/10.1136/bmjgast-2020-000592.

Full text

Abstract:

ObjectiveBenign liver tumours (BLT) are increasingly diagnosed as incidentalomas. Clinical implications and management vary across and within the different types of BLT. High-quality clinical practice guidelines are needed, because of the many nuances in tumour types, diagnostic modalities, and conservative and invasive management strategies. Yet, available observational evidence is subject to interpretation which may lead to practice variation. Therefore, we aimed to systematically search for available clinical practice guidelines on BLT, to critically appraise them, and to compare management

APA, Harvard, Vancouver, ISO, and other styles

48

Cabassa, P., L. Romanini, L. Grazioli, C. Vielmi, and F. Simeone. "Color Doppler ultrasound characterization of focal nodular hyperplasia (FNH): feeding arteries as a typical pattern?" Ultrasound in Medicine & Biology 29, no. 5 (2003): S224. http://dx.doi.org/10.1016/s0301-5629(03)00871-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

ADACHI, Atsushi, Kiyoshi YOSIMURA, Kohsuke TADA, Toshihiro SAEKI, Tetsuji UCHIYAMA, and Takuo MURAKAMI. "A RESECTED CASE OF FOCAL NODULAR HYPERPLASIA (FNH) WITH NODULAR REGENERATIVE HYPERPLASIA OF THE LIVER." Journal of the Japanese Practical Surgeon Society 58, no. 11 (1997): 2611–15. http://dx.doi.org/10.3919/ringe1963.58.2611.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Katrich, A. N., V. A. Porkhanov, and N. S. Ryabin. "Efficacy evaluation of the CEUS-LI-RADS-v2017 system in differential diagnosis of liver tumors." Medical Visualization, no. 4 (December 26, 2019): 57–67. http://dx.doi.org/10.24835/1607-0763-2019-4-57-67.

Full text

Abstract:

Objective: efficacy evaluation of the CEUS LI RADS v2017® system for differential diagnosis of liver tumors in patients with and without cirrhosis.Materials and methods. Retrospective analysis of diagnostic results of the 165 patients with liver tumors (177 nodules) was done. All patients underwent CEUS with results interpretation in accordance to the CEUS LIRADSv2017 ® criteria. Patients were divided into 2 groups based on clinical and morphological data. Group 1 included 62 patients with cirrhosis and/or CVH. Group 2 included 110 patients without risk factors for HCC.Results. Diagnostic effi

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!